Add like
Add dislike
Add to saved papers

Down-regulation of TGF-β RII expression is correlated with tumor growth and invasion in non-functioning pituitary adenomas.

The two types of TGF-β receptors play a crucial role in TGF-β signaling. It has been reported that TGF-β signaling activity may be associated with the development and invasion of NFPAs. However, the role of TGF-β receptor signaling in NFPAs has not been fully explored. In this study, the expression of TGF-β RI and TGF-β RII in normal anterior pituitaries, invasive NFPAs and non-invasive NFPAs was analyzed by qRT-PCR, western blot, and immunohistochemistry. We found that TGF-β RII protein and mRNA levels gradually decreased from normal anterior pituitaries, noninvasive NFPAs to invasive NFPAs. There was no significant difference in the expression of TGF-β RI mRNA and protein level between normal anterior pituitaries and NFPAs. PCNA mRNA level was significantly higher in the invasive NFPAs than noninvasive NFPAs and PCNA mRNA had a negative correlation with TGF-β RII mRNA. We may draw the conclusion that low expression of TGF-β RII may contribute to the development and invasion of NFPAs and TGF-β RII promises to be a useful biomarker for the diagnosis of invasive NFPAs.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app